Sweden· SE-20050507000052
Desferal 500 mg Pulver till injektions-/infusionsvätska, lösning
A medicinal product containing deferoxamine mesilate, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Deferoxamine Mesilate
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20050507000052
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Deferoxamine mesilate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayDesferal2care4 ApS
- NetherlandsDesferal, poeder voor oplossing voor injectie of infusie 500 mgEureco-Pharma B.V.
- IcelandDesferalMitem Pharma
- SpainDESFERIN 500 mg POLVO PARA SOLUCION INYECTABLE O PERFUSIONMitem Pharma
- ItalyDEFEROXAMINA NORIDEMNORIDEM ENTERPRISES LTD
- IrelandDesferal 500mg Vials Powder for Solution for Injection or Powder for Concentrate for Solution for InfusionMitem Pharma
- United StatesDeferoxamineFresenius Kabi USA, LLC
- United KingdomDesferal 2g powder for solution for injection vialsNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Desferal
- Belgium · Desferal
- Bulgaria · Десферал
- Cyprus · Deferoxamine Noridem
- Czechia · Desferal
- Germany · Deferoxaminmesilat Noridem Enterprises, Desferal
- Denmark · Desferal
- Spain · Desferin
- Finland · Desferal
- France · Desferal
- United Kingdom (Northern Ireland) · Desferrioxamine Mesilate Noridem Enterprises
- Greece · Deferoxamine Noridem, Demoferidon
- Hungary · Desferal
- Ireland · Desferal
- Iceland · Desferal
- Italy · Deferoxamina Noridem, Desferal
- Luxembourg · Desferal
- Netherlands · Desferal
- Norway · Desferal
- Poland · Desferal
- Portugal · Desferal
- Romania · Desferal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd7776d3-8f3c-4cc1-9c81-e5692076ce1d GET /v1/drugs/bd7776d3-8f3c-4cc1-9c81-e5692076ce1d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20050507000052",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050507000052",
"product_doc_link": "https://docetp.mpa.se/LMF/Desferal%20500%20mg%20powder%20for%20solution%20for%20injection%20or%20infusion%20EL%20PL_09001bee807a103b.pdf"
}See everything about deferoxamine mesilate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.